Cargando…
LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson’s disease: a review
Parkinson’s disease (PD) is the most common movement disorder and manifests as resting tremor, rigidity, bradykinesia, and postural instability. Pathologically, PD is characterized by selective loss of dopaminergic neurons in the substantia nigra and the formation of intracellular inclusions contain...
Autores principales: | Chen, Meng-Ling, Wu, Ruey-Meei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000924/ https://www.ncbi.nlm.nih.gov/pubmed/29903014 http://dx.doi.org/10.1186/s12929-018-0454-0 |
Ejemplares similares
-
Roco Proteins and the Parkinson’s Disease-Associated LRRK2
por: Liao, Jingling, et al.
Publicado: (2018) -
Homozygous mutation of the LRRK2 ROC domain as a novel genetic model of parkinsonism
por: Chen, Meng-Ling, et al.
Publicado: (2022) -
The LRRK2-related Roco kinase Roco2 is regulated by Rab1A and controls the actin cytoskeleton
por: Kicka, Sebastian, et al.
Publicado: (2011) -
A Conserved Role for LRRK2 and Roco Proteins in the Regulation of Mitochondrial Activity
por: Rosenbusch, Katharina E., et al.
Publicado: (2021) -
Mutational Analysis of Angiogenin Gene in Parkinson's Disease
por: Chen, Meng-Ling, et al.
Publicado: (2014)